SBN
Click for more information
0.00% 0.0¢ sun biomedical limited

News: Sun Biomedical heads to market

  1. Proactive
    clock Created with Sketch.
    10/09/14
    12:10
    Post #: 13952468

    Sun Biomedical (ASX:SBN) will announce a capital raising after it exits a trading halt by Friday 12 September.

    The biotechnology and medical device company completed the first phase of testing of a new device aimed at occupational drug testing.

    There is a global trend towards saliva based occupational drug testing.

    The company is also known to be running the ruler over medical device acquisitions.


    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.